A Primary Mediastinal Large B-Cell Lymphoma Patient With COVID-19 Infection After Intensive Immunochemotherapy: A Case Report

Background: The outbreak of coronavirus disease 2019 (COVID-19) had become a global public health event. Lymphoma patients need to be distinguished from the general population because of their deficient immune status and intensive anti-tumor treatment. The impacts of cancer subtypes and treatment on...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Qiuhui, Zhu, Fang, Xiao, Yin, Liu, Tao, Liu, Xinxiu, Wu, Gang, Zhang, Liling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7256193/
https://www.ncbi.nlm.nih.gov/pubmed/32574278
http://dx.doi.org/10.3389/fonc.2020.00924

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7256193/
https://www.ncbi.nlm.nih.gov/pubmed/32574278
http://dx.doi.org/10.3389/fonc.2020.00924

Ejemplares similares